AI assistant
TALGA GROUP LTD — Capital/Financing Update 2014
Mar 20, 2014
65925_rns_2014-03-20_3f036b30-ba81-4bb6-aad9-f36fd812d215.pdf
Capital/Financing Update
Open in viewerOpens in your device viewer
21 MARCH, 2014
ASX: TLG
==> picture [71 x 45] intentionally omitted <==
~~TALGA~~ R E S O U R C E S
Talga Resources Ltd ABN 32 138 405 419 1st Floor, 2 Richardson St, West Perth, WA 6005 T: +61 8 9481 6667 F: +61 8 9322 1935 www.talgaresources.com
TALGA RESOURCES COMPLETES $1.7M PLACEMENT
Talga Resources Limited ("Talga” or the Company") is pleased to announce that it has received $1.7million in funds as part of a placement to professional and sophisticated investors via the issue of 20 million ordinary shares at 8.5 cents per ordinary share (“Placement”).
11,519,991 shares were issued pursuant to the Company’s 15% capacity under ASX Listing Rule 7.1 and 8,480,009 shares were issued pursuant to the Company’s 10% capacity under ASX Listing Rule 7.1A.
The Company annexures an Appendix 3B and provides the following information required under ASX Listing Rule 3.10.5A:
- a) The dilutive effect of the issue of the shares is 19%.
Corporate Information ASX Code TLG Shares on issue 105.1m Options (unlisted) 3.75m
-
b) The Company issued the 8,480,009 shares under Listing Rule 7.1A as it believes this is the most efficient mechanism for raising funds to meet its stated objectives and the Placement was considered the most appropriate of the opportunities that were considered by the Board.
-
c) The Placement was offered to a range of professional and sophisticated investors and accordingly, there was no need for an underwriter.
Company Directors Keith Coughlan Non-Executive Chairman
- d) Broker fees incurred in connection with the Placement were $102,000. There were no other costs associated with the Placement other than regulatory and compliance costs.
Managing Director’s Comment
Mark Thompson Managing Director
Grant Mooney Non-Executive Director
“The Company is now fully funded to complete metallurgical and other tests that will result in a dual graphite/graphene preliminary economic study of the Nunasvaara graphite project in northern Sweden. The Placement attracted encouraging support from major shareholders including Yandal Investments Pty Ltd, a company controlled by prominent prospector Mark Creasy plus new shareholders with significant interest in the graphite space.”
For further information, contact:
Mark Thompson
Managing Director
Talga Resources Ltd Tel +61 (08) 9481 6667 Email [email protected]
www.talgaresources.com
==> picture [12 x 12] intentionally omitted <==
ASX Code: TLG
TALGA RESOURCES LTD ASX AND MEDIA RELEASE
PAGE 1
Appendix
3B New
issue
announcement
Rule
2.7,
3.10.3,
3.10.4,
3.10.5
Appendix 3B
New issue announcement, application for quotation of additional securities and agreement
Information
or
documents
not
available
now
must
be
given
to
ASX
as
soon
as
available.
Information
and documents
given
to
ASX
become
ASX’s
property
and
may
be
made
public.
Introduced
01/07/96
Origin:
Appendix
5
Amended
01/07/98,
01/09/99,
01/07/00,
30/09/01,
11/03/02,
01/01/03,
24/10/05,
01/08/12, 04/03/13
Name
of
entity
**TALGA
RESOURCES
LTD**
ABN
32
138
405
419
We
(the
entity)
give
ASX
the
following
information.
Part 1 - All issues
You
must
complete
the
relevant
sections
(attach
sheets
if
there
is
not
enough
space).
| 1 +Class of+securities issued or to be issued 2 Number of+securities issued or to be issued (if known) or maximum number which may be issued 3 Principal terms of the +securities (e.g. if options, exercise price and expiry date; if partly paid +securities, the amount outstanding and due dates for payment; if +convertible securities, the conversion price and dates for conversion) |
Ordinary Shares |
|---|---|
| 20,000,000 | |
Fully paid ordinary shares |
- See
chapter
19
for
defined
terms.
04/03/2013
Appendix
3B
Page
1
Appendix
3B New
issue
announcement
4 Do the+securities rank equally in all respects from the+issue date with an existing+class of quoted+securities? If the additional+securities do not rank equally, please state: • the date from which they do • the extent to which they participate for the next dividend, (in the case of a trust, distribution) or interest payment • the extent to which they do not rank equally, other than in relation to the next dividend, distribution or interest payment 5 Issue price or consideration 6 Purpose of the issue (If issued as consideration for the acquisition of assets, clearly identify those assets) 6a Is the entity an+eligible entity that has obtained security holder approval under rule 7.1A? If Yes, complete sections 6b – 6h in relation to the+securities the subject of this Appendix 3B, and comply with section 6i 6b The date the security holder resolution under rule 7.1A was passed 6c Number of+securities issued without security holder approval under rule 7.1 |
|
|---|---|
| Yes | |
| $0.085 per share | |
| Issue of shares to professional and sophisticated investors to fund graphite and graphene metallurgy, upscaling tests, economic studies, exploration and working capital. |
|
| Yes | |
| 21 November 2013 | |
| 12,720,013 | |
- See
chapter
19
for
defined
terms.
Appendix
3B
Page
2
04/03/2013
Appendix
3B New
issue
announcement
| 6d Number of+securities issued with security holder approval under rule 7.1A 6e Number of+securities issued with security holder approval under rule 7.3, or another specific security holder approval (specify date of meeting) 6f Number of+securities issued under an exception in rule 7.2 6g If+securities issued under rule 7.1A, was issue price at least 75% of 15 day VWAP as calculated under rule 7.1A.3? Include the +issue date and both values. Include the source of the VWAP calculation. 6h If+securities were issued under rule 7.1A for non-cash consideration, state date on which valuation of consideration was released to ASX Market Announcements 6i Calculate the entity’s remaining issue capacity under rule 7.1 and rule 7.1A – complete Annexure 1 and release to ASX Market Announcements 7 +Issue dates Note: The issue date may be prescribed by ASX (refer to the definition of issue date in rule 19.12). For example, the issue date for a pro rata entitlement issue must comply with the applicable timetable in Appendix 7A. Cross reference: item 33 of Appendix 3B. 8 Number and +class of all +securities quoted on ASX (_including_the +securities in section 2 if applicable) |
8,480,009 | 8,480,009 |
|---|---|---|
| N/A | ||
| N/A | ||
| Yes – the calculated price, prepared internally by the Company that is 75% of the 15 day VWAP prior to the date on which the price was agreed of 17 March 2014 is $0.072. The issue price of the 20 million shares, issued on 20 March 2014 is $0.085 which is greater than the calculated price. |
||
| N/A | ||
| Capacity under LR 7.1 is 940,022 Capacity under LR 7.1A is Nil |
||
| 21 March 2014 | ||
| Number | ~~+~~Class | |
| 105,060,089 | Ordinary fully paid shares |
- See
chapter
19
for
defined
terms.
04/03/2013
Appendix
3B
Page
3
Appendix
3B New
issue
announcement
Number +Class 9 Number and +class of all 500,000 Unlisted
$0.35
options,
expiry
21
July +securities
not
quoted
on
ASX 2015 ( including the +securities
in section
2
if
applicable) 500,000 Unlisted
$0.45
options,
expiry
3 October
2016 2,750,000 Unlisted
$0.40
options,
expiry
30 November
2014 10 Dividend
policy
(in
the
case
of
a N/A trust,
distribution
policy)
on
the increased
capital
(interests)
Part 2 - Pro rata issue
| 11 Is security holder approval required? 12 Is the issue renounceable or non- renounceable? 13 Ratio in which the+securities will be offered 14 +Class of+securities to which the offer relates 15 +Record date to determine entitlements 16 Will holdings on different registers (or subregisters) be aggregated for calculating entitlements? 17 Policy for deciding entitlements in relation to fractions 18 Names of countries in which the entity has security holders who will not be sent new offer documents Note: Security holders must be told how their entitlements are to be dealt with. Cross reference: rule 7.7. 19 Closing date for receipt of acceptances or renunciations |
N/A |
|---|---|
| N/A | |
| N/A | |
| N/A | |
| N/A | |
| N/A | |
| N/A | |
| N/A | |
| N/A |
- See
chapter
19
for
defined
terms.
Appendix
3B
Page
4
04/03/2013
Appendix
3B New
issue
announcement
20 Names of any underwriters 21 Amount of any underwriting fee or commission 22 Names of any brokers to the issue 23 Fee or commission payable to the broker to the issue 24 Amount of any handling fee payable to brokers who lodge acceptances or renunciations on behalf of security holders 25 If the issue is contingent on security holders’ approval, the date of the meeting 26 Date entitlement and acceptance form and offer documents will be sent to persons entitled 27 If the entity has issued options, and the terms entitle option holders to participate on exercise, the date on which notices will be sent to option holders 28 Date rights trading will begin (if applicable) 29 Date rights trading will end (if applicable) 30 How do security holders sell their entitlements_in full_through a broker? 31 How do security holders sell_part_ of their entitlements through a broker and accept for the balance? |
N/A |
|---|---|
| N/A | |
| N/A | |
| N/A | |
| N/A | |
| N/A | |
| N/A | |
| N/A | |
| N/A | |
| N/A | |
| N/A | |
| N/A | |
- See
chapter
19
for
defined
terms.
04/03/2013
Appendix
3B
Page
5
Appendix
3B New
issue
announcement
-
32 How
do
security
holders
dispose N/A of
their
entitlements
(except
by sale
through
a
broker)? -
33 +Issue
date N/A
Part 3 - Quotation of securities
You
need
only
complete
this
section
if
you
are
applying
for
quotation
of
securities
-
34 Type
of[+] securities ( tick
one ) -
(a) P +Securities
described
in
Part
1 -
(b)[All
other
][+][securities
]
Example:
restricted
securities
at
the
end
of
the
escrowed
period,
partly
paid
securities
that
become
fully
paid, employee
incentive
share
securities
when
restriction
ends,
securities
issued
on
expiry
or
conversion
of
convertible securities
Entities that have ticked box 34(a)
**Additional
securities
forming
a
new
class
of
securities**
Tick
to
indicate
you
are
providing
the
information
or documents
35 If
the[+] securities
are[+] equity
securities,
the
names
of
the
20
largest
holders
of
the additional[+] securities,
and
the
number
and
percentage
of
additional[+] securities held
by
those
holders
-
36
-
If
the[+] securities
are[+] equity
securities,
a
distribution
schedule
of
the
additional +securities
setting
out
the
number
of
holders
in
the
categories -
1
-‐
1,000 -
1,001
-‐
5,000 -
5,001
-‐
10,000
10,001
-‐
100,000
100,001
and
over
-
37 A
copy
of
any
trust
deed
for
the
additional[+] securities -
See
chapter
19
for
defined
terms.
Appendix
3B
Page
6
Appendix
3B New
issue
announcement
Entities that have ticked box 34(b)
38 Number
of[+] securities
for
which N/A +quotation
is
sought 39 +Class
of +securities
for
which N/A quotation
is
sought 40 Do
the[+] securities
rank
equally
in N/A all
respects
from
the[+] issue
date with
an
existing[+] class
of
quoted +securities? If
the
additional[+] securities
do not
rank
equally,
please
state: • the
date
from
which
they
do • the
extent
to
which
they participate for the next dividend,
(in
the
case
of
a trust,
distribution)
or
interest payment • the
extent
to
which
they
do not
rank
equally,
other
than
in relation
to
the
next
dividend, distribution or interest payment 41 Reason
for
request
for
quotation N/A
41 Reason
for
request
for
quotation now
Example:
In
the
case
of
restricted
securities,
end of
restriction
period
(if
issued
upon
conversion
of another[+] security,
clearly
identify that
other[+] security)
Number +Class 42 Number and +class of all N/A +securities quoted on ASX ( including the[+] securities
in
clause 38)
- See
chapter
19
for
defined
terms.
04/03/2013
Appendix
3B
Page
7
Appendix
3B New
issue
announcement
**Quotation
agreement**
-
1 +Quotation
of
our
additional +securities
is
in
ASX’s
absolute
discretion.
ASX may
quote
the[+] securities
on
any
conditions
it
decides. -
2 We
warrant
the
following
to
ASX. -
The
issue
of
the[+] securities
to
be
quoted
complies
with
the
law
and
is not
for
an
illegal
purpose. -
There
is
no
reason
why
those[+] securities
should
not
be
granted + quotation. -
An
offer
of
the[+] securities
for
sale
within
12
months
after
their
issue will
not
require
disclosure
under
section
707(3)
or
section
1012C(6)
of the
Corporations
Act.
Note:
An
entity
may
need
to
obtain
appropriate
warranties
from
subscribers
for
the
securities
in
order
to
be able
to
give
this
warranty
-
Section
724
or
section
1016E
of
the
Corporations
Act
does
not
apply
to any
applications
received
by
us
in
relation
to
any[+] securities
to
be quoted
and
that
no-‐one
has
any
right
to
return
any[+] securities
to
be quoted
under
sections
737,
738
or
1016F
of
the
Corporations
Act
at
the time
that
we
request
that
the[+] securities
be
quoted. -
If
we
are
a
trust,
we
warrant
that
no
person
has
the
right
to
return
the +securities
to
be
quoted
under
section
1019B
of
the
Corporations
Act
at the
time
that
we
request
that
the[+] securities
be
quoted. -
3 We
will
indemnify
ASX
to
the
fullest
extent
permitted
by
law
in
respect
of
any claim,
action
or
expense
arising
from
or
connected
with
any
breach
of
the warranties
in
this
agreement. -
4 We
give
ASX
the
information
and
documents
required
by
this
form.
If
any information
or
document
is
not
available
now,
we
will
give
it
to
ASX
before +quotation
of
the +securities
begins.
We
acknowledge
that
ASX
is
relying
on the
information
and
documents.
We
warrant
that
they
are
(will
be)
true
and complete.
Sign
here: ............................................................Date:
21
March
2014 (Company
secretary)
Print
name: Lisa
Wynne
- See
chapter
19
for
defined
terms.
Appendix
3B
Page
8
Appendix
3B New
issue
announcement
Appendix 3B – Annexure 1
Calculation of placement capacity under rule 7.1 and rule 7.1A for eligible entities
Introduced
01/08/12
Amended
04/03/13
Part 1
Rule 7.1 – Issues exceeding 15% of capital
Step 1: Calculate “A”, the base figure from which the placement capacity is calculated
==> picture [415 x 404] intentionally omitted <==
----- Start of picture text -----
Insert number of fully paid [+] ordinary 54,404,407
securities on issue 12 months before the
+issue date or date of agreement to issue
Add the following:
• Number of fully paid [+] ordinary securities
30,395,682
issued in that 12 month period under an
exception in rule 7.2
• Number of fully paid [+] ordinary securities
issued in that 12 month period with
shareholder approval
• Number of partly paid [+] ordinary
securities that became fully paid in that
12 month period
Note:
• Include only ordinary securities here –
other classes of equity securities cannot
be added
• Include here (if applicable) the securities
the subject of the Appendix 3B to which
this form is annexed
• It may be useful to set out issues of
securities on different dates as separate
line items
Subtract the number of fully paid [+] ordinary Nil
securities cancelled during that 12 month
period
“A” 84,800,089
----- End of picture text -----
- See
chapter
19
for
defined
terms.
04/03/2013
Appendix
3B
Page
9
Appendix
3B New
issue
announcement
| Appendix 3B New issue announcement |
Appendix 3B New issue announcement |
|---|---|
| Step 2: Calculate 15% of “A” | |
| “B” | 0.15 [Note: this value cannot be changed] |
| Multiply“A” by 0.15 | 12,720,013 |
| Step 3: Calculate “C”, the amount of placement capacity under rule 7.1 that has already been used |
|
| Insertnumber of+equity securities issued or agreed to be issued in that 12 month period_not counting_those issued: • Under an exception in rule 7.2 • Under rule 7.1A • With security holder approval under rule 7.1 or rule 7.4 Note: • This applies to equity securities, unless specifically excluded – not just ordinary securities • Include here (if applicable) the securities the subject of the Appendix 3B to which this form is annexed • It may be useful to set out issues of securities on different dates as separate line items |
260,000 issued to contractors on 21/11/13 11,519,991 issued to professional & sophisticated investors on 21/03/14 |
| “C” | |
| Step 4: Subtract “C” from [“A” x “B”] to calculate remaining placement capacity under rule 7.1 |
|
| “A” x 0.15 Note: number must be same as shown in Step 2 |
12,720,013 |
| Subtract“C” Note: number must be same as shown in Step 3 |
11,779,991 |
| Total[“A” x 0.15] – “C” | 940,022 [Note: this is the remaining placement capacity under rule 7.1] |
- See
chapter
19
for
defined
terms.
Appendix
3B
Page
10
Appendix
3B New
issue
announcement
Part 2
| New issue announcement Part 2 |
New issue announcement Part 2 |
|---|---|
| Rule 7.1A – Additional placement capacity for eligible entities | |
| Step 1: Calculate “A”, the base figure from which the placement capacity is calculated |
|
| “A” Note: number must be same as shown in Step 1 of Part 1 |
84,800,089 |
| Step 2: Calculate 10% of “A” | |
| “D” | 0.10 Note: this value cannot be changed |
| Multiply“A” by 0.10 | 8,480,009 |
| Step 3: Calculate “E”, the amount of placement capacity under rule 7.1A that has already been used |
|
| Insertnumber of+equity securities issued or agreed to be issued in that 12 month period under rule 7.1A Notes: • This applies to equity securities – not just ordinary securities • Include here – if applicable – the securities the subject of the Appendix 3B to which this form is annexed • Do not include equity securities issued under rule 7.1 (they must be dealt with in Part 1), or for which specific security holder approval has been obtained • It may be useful to set out issues of securities on different dates as separate line items |
8,480,009 issued to professional & sophisticated investors on 21/03/14 |
| “E” | 8,480,009 |
- See
chapter
19
for
defined
terms.
04/03/2013
Appendix
3B
Page
11
Appendix
3B New
issue
announcement
| Appendix 3B New issue announcement |
Appendix 3B New issue announcement |
|---|---|
| Step 4: Subtract “E” from [“A” x “D”] to calculate remaining placement capacity under rule 7.1A |
|
| “A” x 0.10 Note: number must be same as shown in Step 2 |
8,480,009 |
| Subtract“E” Note: number must be same as shown in Step 3 |
8,480,009 |
| Total[“A” x 0.10] – “E” | Nil Note: this is the remaining placement capacity under rule 7.1A |
- See
chapter
19
for
defined
terms.
Appendix
3B
Page
12